首页> Journal of immunotherapy (Hagerstown, Md. : 1997)> Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden.

Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden.

导出 LinkOut

翻译打印收藏纠错

第一作者： Changju,Qu

第一单位： Departments of Hematology, Jiangsu Institute of Hematology.;Institute of Blood and Marrow Transplantation.;Collaborative Innovation Center of Hematology, Soochow University, Suzhou.

作者： Changju,Qu ^[1] ; Nana,Ping ^[1] ; Liqing,Kang ^[2] ; Hailing,Liu ^[3] ; Songbin,Qin ^[4] ; Qian,Wu ^[1] ; Xiaochen,Chen ^[1] ; Meng,Zhou ^[1] ; Fan,Xia ^[5] ; Aihua,Ye ^[6] ; Danqing,Kong ^[1] ; Caixia,Li ^[1] ; Lei,Yu ^[2] ; Depei,Wu ^[1] ; Zhengming,Jin ^[1]

作者单位： Departments of Hematology, Jiangsu Institute of Hematology.;Institute of Blood and Marrow Transplantation.;Collaborative Innovation Center of Hematology, Soochow University, Suzhou. ^[1] School of Chemistry and Molecular Engineering, East China Normal University.;Shanghai Unicar-Therapy Bio-medicine Technology Co. Ltd, Shanghai. ^[2] Department of Radiology, People's Hospital of Binhai County, Jiangsu, China. ^[3] Radiotherapy. ^[4] Pharmacy. ^[5] Radiology, the First Affiliated Hospital of Soochow University. ^[6]